TD Cowen Upgrades Aspen Aerogels (NYSE:ASPN) to Strong-Buy

TD Cowen upgraded shares of Aspen Aerogels (NYSE:ASPN) to a strong-buy rating in a research note released on Tuesday,Zacks.com reports.

Several other equities research analysts have also recently issued reports on the stock. Canaccord Genuity Group lowered their target price on shares of Aspen Aerogels from $20.00 to $15.00 and set a “buy” rating on the stock in a research note on Friday, February 14th. StockNews.com upgraded shares of Aspen Aerogels to a “sell” rating in a report on Wednesday, February 19th. Barclays dropped their target price on Aspen Aerogels from $25.00 to $13.00 and set an “overweight” rating for the company in a report on Wednesday, February 19th. Roth Mkm cut their price target on shares of Aspen Aerogels from $22.00 to $16.00 and set a “buy” rating for the company in a report on Friday, February 14th. Finally, Craig Hallum reduced their price target on shares of Aspen Aerogels from $21.00 to $18.00 and set a “buy” rating on the stock in a research report on Friday, February 14th. One research analyst has rated the stock with a sell rating, one has assigned a hold rating, eight have assigned a buy rating and one has assigned a strong buy rating to the company. According to data from MarketBeat, Aspen Aerogels currently has an average rating of “Moderate Buy” and a consensus price target of $19.11.

Aspen Aerogels Stock Down 3.3 %

Shares of NYSE ASPN opened at $7.44 on Tuesday. Aspen Aerogels has a 52-week low of $6.70 and a 52-week high of $33.15. The company has a quick ratio of 2.48, a current ratio of 2.93 and a debt-to-equity ratio of 0.27. The company’s 50-day simple moving average is $10.53 and its 200-day simple moving average is $16.44. The firm has a market cap of $610.11 million, a price-to-earnings ratio of 46.47 and a beta of 2.28.

Aspen Aerogels (NYSE:ASPN) last posted its quarterly earnings data on Wednesday, February 12th. The construction company reported $0.15 EPS for the quarter, topping the consensus estimate of $0.04 by $0.11. Aspen Aerogels had a return on equity of 7.49% and a net margin of 2.95%. Equities analysts predict that Aspen Aerogels will post 0.17 EPS for the current fiscal year.

Institutional Investors Weigh In On Aspen Aerogels

A number of large investors have recently modified their holdings of the company. Millennium Management LLC increased its holdings in Aspen Aerogels by 4,757.8% in the fourth quarter. Millennium Management LLC now owns 1,622,022 shares of the construction company’s stock valued at $19,270,000 after buying an additional 1,588,632 shares during the last quarter. Point72 Asset Management L.P. purchased a new position in Aspen Aerogels in the fourth quarter valued at approximately $13,122,000. Alyeska Investment Group L.P. purchased a new position in shares of Aspen Aerogels in the 4th quarter valued at $9,504,000. Dendur Capital LP purchased a new stake in Aspen Aerogels in the fourth quarter valued at $9,207,000. Finally, FMR LLC boosted its holdings in shares of Aspen Aerogels by 23.6% in the third quarter. FMR LLC now owns 4,050,896 shares of the construction company’s stock valued at $112,169,000 after acquiring an additional 773,647 shares during the period. 97.64% of the stock is owned by hedge funds and other institutional investors.

Aspen Aerogels Company Profile

Aspen Aerogels, Inc designs, develops, manufactures, and sells aerogel insulation products primarily for use in the energy infrastructure and sustainable insulation materials markets in the United States, Asia, Canada, Europe, and Latin America. It operates in two segments, Energy Industrial and Thermal Barrier.